Lasantha R Bandara

Title: Lasantha R Bandara: Innovator in Peptide Antagonists

Introduction

Lasantha R Bandara is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biochemistry, particularly in the development of peptide antagonists that target transcription factors.

Latest Patents

Lasantha holds two patents related to peptide antagonists of DP transcription factors. His inventions provide polypeptides that consist essentially of a sequence corresponding to residues 163 to 199 of DP-1. These polypeptides and their fragments are capable of antagonizing the heterodimerization of a DP protein with an E2F protein. Such peptides can induce apoptosis in cardiovascular cells by introducing an effective amount of the peptide into the cell. Additionally, these peptides may be delivered in a stent to treat or prevent restenosis.

Career Highlights

Lasantha is currently associated with Prolifix Limited, where he continues to innovate in the field of peptide research. His work has the potential to impact therapeutic approaches in cardiovascular medicine.

Collaborations

Lasantha collaborates with Nicholas B La Thangue, enhancing the research and development of his innovative ideas.

Conclusion

Lasantha R Bandara is a prominent inventor whose work on peptide antagonists has the potential to revolutionize treatments for cardiovascular diseases. His contributions to science and medicine are noteworthy and continue to inspire future innovations.